Capavita SRL
Capavita reported total assets of €1.09m at the end of the 2026 financial year (annual accounts filed with the NBB on 29 Sep 2026).
The score of Capavita shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +5 % Total assets +4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Capavita's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | 114,652 € | ||||
| Equity | 790,756 € | ||||
| Cash | 189,015 € | ||||
| EBITDA | 188,175 € | ||||
| Total assets | €1.09m |
Filed annual accounts
- Year ended 31 Mar 2026filed on 29 Sep 2026
- Year ended 31 Mar 2025filed on 23 Oct 2025
- Year ended 31 Mar 2024filed on 23 Oct 2024
- Year ended 31 Mar 2023filed on 11 Sep 2023
- Year ended 31 Mar 2022filed on 01 Sep 2022
Capavita's financial analysis
- Solvency72.7%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Capavita
Capavita's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0567.565.014
- VAT number
- BE0567565014
- Peppol
- Registered · 0208:0567565014 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Oct 2014
- Registered office
- 2900 Schoten
- Latest accounts
- 2026 · filed on 29 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Capavita (SRL) has been based in Schoten since 2014, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 114,652 € and equity of 790,756 €; its revenue is not published. Its solvency stands at 72.7%, above the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Capavita
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apoteek Mommaert Retail sale of pharmaceutical products Beersel · balance sheet €1.09m
- Van Geem Retail sale of pharmaceutical products Antwerp · balance sheet €1.08m
- Novaka Pharma Retail sale of pharmaceutical products Nivelles · balance sheet €1.10m
- Pharmadvance Retail sale of pharmaceutical products Chièvres · balance sheet €1.07m
- Farma Noord Retail sale of pharmaceutical products Kalmthout · balance sheet €1.12m
- L.V.G. Pharma Retail sale of pharmaceutical products Puurs-Sint-Amands · balance sheet €1.06m
- Chaspierre Holding Retail sale of pharmaceutical products Verviers · balance sheet €1.13m
Frequently asked questions about Capavita
What is the revenue of Capavita?
Capavita files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Capavita?
In Belgium, the VAT number is the company number prefixed with BE: BE0567565014 for Capavita, if the company is VAT-registered. Its company number (CBE) is 0567.565.014.
Where is the registered office of Capavita?
According to the CBE register, the registered office of Capavita is in 2900 Schoten.
What is the equity of Capavita?
At the close of the 2026 financial year, the equity of Capavita amounts to 790,756 €, a solvency of 72.7% of total assets.
Who manages Capavita?
The register lists 2 active mandates at Capavita. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Capavita
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →